AJOONI vs CONTI: Stock Comparison
AJOONI BIOTECH is the larger company by market capitalisation. AJOONI BIOTECH shows a higher ROE, faster revenue growth and a higher ROCE, while CONTI shows lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
AJOONI leads 5; CONTI leads 5 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | AJOONI | CONTI |
|---|---|---|
| Sector | Fast Moving Consumer Goods | — |
| Industry | Animal Feed | — |
Price
| Metric | AJOONI | CONTI |
|---|---|---|
| Live Price | ₹3.16 | — |
| Day Change | -0.63% | — |
| Volume | 2.33 L | — |
| 52-Week High | ₹5.71 | — |
| 52-Week Low | ₹3.02 | — |
| Distance from 52W High | -44.66% | — |
Valuation
| Metric | AJOONI | CONTI |
|---|---|---|
| Market Cap | ₹55 Cr | ₹14 Cr |
| EPS | ₹0.25 | ₹0.72 |
| Book Value | ₹4.81 | ₹23 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | AJOONI | CONTI |
|---|---|---|
| Revenue Growth (TTM YoY) | 103.3% | 0% |
| EPS Growth (TTM YoY) | -44.4% | 0% |
| Qtr Sales Growth | -65.19% | 199.1% |
| Qtr Profit Growth | -90.01% | 425.07% |
Profitability & Leverage
| Metric | AJOONI | CONTI |
|---|---|---|
| ROE | 4.74% | 3.13% |
| ROCE | 4.49% | 4.14% |
| Net Margin | 2.34% | 0% |
| Operating Margin | 3.55% | 2.75% |
| Debt to Equity | 0.19x | 0.09x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | AJOONI | CONTI |
|---|---|---|
| Promoter Holding | 26.89% | 60.75% |
| FII Holding | 0% | 12.19% |
| DII Holding | 0% | 0% |
| Public Holding | 73.11% | 27.06% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AJOONI BIOTECH and CONTI.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.